DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

Maria E. Figueroa, Sanne Lugthart, Yushan Li, Claudia Erpelinck-Verschueren, Xutao Deng, Paul J. Christos, Elizabeth Schifano, James Booth, Wim van Putten, Lucy Skrabanek, Fabien Campagne, Madhu Mazumdar, John M. Greally, Peter J M Valk, Bob Löwenberg, Ruud Delwel, Ari Melnick

Research output: Contribution to journalArticle

517 Citations (Scopus)

Abstract

We hypothesized that DNA methylation distributes into specific patterns in cancer cells, which reflect critical biological differences. We therefore examined the methylation profiles of 344 patients with acute myeloid leukemia (AML). Clustering of these patients by methylation data segregated patients into 16 groups. Five of these groups defined new AML subtypes that shared no other known feature. In addition, DNA methylation profiles segregated patients with CEBPA aberrations from other subtypes of leukemia, defined four epigenetically distinct forms of AML with NPM1 mutations, and showed that established AML1-ETO, CBFb-MYH11, and PML-RARA leukemia entities are associated with specific methylation profiles. We report a 15 gene methylation classifier predictive of overall survival in an independent patient cohort (p < 0.001, adjusted for known covariates).

Original languageEnglish (US)
Pages (from-to)13-27
Number of pages15
JournalCancer Cell
Volume17
Issue number1
DOIs
StatePublished - Jan 19 2010

Fingerprint

DNA Methylation
Acute Myeloid Leukemia
Methylation
Leukemia
Cluster Analysis
Mutation
Survival
Genes
Neoplasms

Keywords

  • CELLCYCLE
  • DNA
  • HUMDISEASE

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Figueroa, M. E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X., Christos, P. J., ... Melnick, A. (2010). DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia. Cancer Cell, 17(1), 13-27. https://doi.org/10.1016/j.ccr.2009.11.020

DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia. / Figueroa, Maria E.; Lugthart, Sanne; Li, Yushan; Erpelinck-Verschueren, Claudia; Deng, Xutao; Christos, Paul J.; Schifano, Elizabeth; Booth, James; van Putten, Wim; Skrabanek, Lucy; Campagne, Fabien; Mazumdar, Madhu; Greally, John M.; Valk, Peter J M; Löwenberg, Bob; Delwel, Ruud; Melnick, Ari.

In: Cancer Cell, Vol. 17, No. 1, 19.01.2010, p. 13-27.

Research output: Contribution to journalArticle

Figueroa, ME, Lugthart, S, Li, Y, Erpelinck-Verschueren, C, Deng, X, Christos, PJ, Schifano, E, Booth, J, van Putten, W, Skrabanek, L, Campagne, F, Mazumdar, M, Greally, JM, Valk, PJM, Löwenberg, B, Delwel, R & Melnick, A 2010, 'DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia', Cancer Cell, vol. 17, no. 1, pp. 13-27. https://doi.org/10.1016/j.ccr.2009.11.020
Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, Christos PJ et al. DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia. Cancer Cell. 2010 Jan 19;17(1):13-27. https://doi.org/10.1016/j.ccr.2009.11.020
Figueroa, Maria E. ; Lugthart, Sanne ; Li, Yushan ; Erpelinck-Verschueren, Claudia ; Deng, Xutao ; Christos, Paul J. ; Schifano, Elizabeth ; Booth, James ; van Putten, Wim ; Skrabanek, Lucy ; Campagne, Fabien ; Mazumdar, Madhu ; Greally, John M. ; Valk, Peter J M ; Löwenberg, Bob ; Delwel, Ruud ; Melnick, Ari. / DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia. In: Cancer Cell. 2010 ; Vol. 17, No. 1. pp. 13-27.
@article{e9c77b85813847498496a024600f98e2,
title = "DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia",
abstract = "We hypothesized that DNA methylation distributes into specific patterns in cancer cells, which reflect critical biological differences. We therefore examined the methylation profiles of 344 patients with acute myeloid leukemia (AML). Clustering of these patients by methylation data segregated patients into 16 groups. Five of these groups defined new AML subtypes that shared no other known feature. In addition, DNA methylation profiles segregated patients with CEBPA aberrations from other subtypes of leukemia, defined four epigenetically distinct forms of AML with NPM1 mutations, and showed that established AML1-ETO, CBFb-MYH11, and PML-RARA leukemia entities are associated with specific methylation profiles. We report a 15 gene methylation classifier predictive of overall survival in an independent patient cohort (p < 0.001, adjusted for known covariates).",
keywords = "CELLCYCLE, DNA, HUMDISEASE",
author = "Figueroa, {Maria E.} and Sanne Lugthart and Yushan Li and Claudia Erpelinck-Verschueren and Xutao Deng and Christos, {Paul J.} and Elizabeth Schifano and James Booth and {van Putten}, Wim and Lucy Skrabanek and Fabien Campagne and Madhu Mazumdar and Greally, {John M.} and Valk, {Peter J M} and Bob L{\"o}wenberg and Ruud Delwel and Ari Melnick",
year = "2010",
month = "1",
day = "19",
doi = "10.1016/j.ccr.2009.11.020",
language = "English (US)",
volume = "17",
pages = "13--27",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

AU - Figueroa, Maria E.

AU - Lugthart, Sanne

AU - Li, Yushan

AU - Erpelinck-Verschueren, Claudia

AU - Deng, Xutao

AU - Christos, Paul J.

AU - Schifano, Elizabeth

AU - Booth, James

AU - van Putten, Wim

AU - Skrabanek, Lucy

AU - Campagne, Fabien

AU - Mazumdar, Madhu

AU - Greally, John M.

AU - Valk, Peter J M

AU - Löwenberg, Bob

AU - Delwel, Ruud

AU - Melnick, Ari

PY - 2010/1/19

Y1 - 2010/1/19

N2 - We hypothesized that DNA methylation distributes into specific patterns in cancer cells, which reflect critical biological differences. We therefore examined the methylation profiles of 344 patients with acute myeloid leukemia (AML). Clustering of these patients by methylation data segregated patients into 16 groups. Five of these groups defined new AML subtypes that shared no other known feature. In addition, DNA methylation profiles segregated patients with CEBPA aberrations from other subtypes of leukemia, defined four epigenetically distinct forms of AML with NPM1 mutations, and showed that established AML1-ETO, CBFb-MYH11, and PML-RARA leukemia entities are associated with specific methylation profiles. We report a 15 gene methylation classifier predictive of overall survival in an independent patient cohort (p < 0.001, adjusted for known covariates).

AB - We hypothesized that DNA methylation distributes into specific patterns in cancer cells, which reflect critical biological differences. We therefore examined the methylation profiles of 344 patients with acute myeloid leukemia (AML). Clustering of these patients by methylation data segregated patients into 16 groups. Five of these groups defined new AML subtypes that shared no other known feature. In addition, DNA methylation profiles segregated patients with CEBPA aberrations from other subtypes of leukemia, defined four epigenetically distinct forms of AML with NPM1 mutations, and showed that established AML1-ETO, CBFb-MYH11, and PML-RARA leukemia entities are associated with specific methylation profiles. We report a 15 gene methylation classifier predictive of overall survival in an independent patient cohort (p < 0.001, adjusted for known covariates).

KW - CELLCYCLE

KW - DNA

KW - HUMDISEASE

UR - http://www.scopus.com/inward/record.url?scp=73649110641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649110641&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2009.11.020

DO - 10.1016/j.ccr.2009.11.020

M3 - Article

VL - 17

SP - 13

EP - 27

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 1

ER -